Log in or Sign up for Free to view tailored content for your specialty!
Vascular Medicine News
Beta-blockers may not help after acute heart attack if ejection fraction preserved
ATLANTA — In patients who underwent early angiography for acute MI and had ejection fraction of 50% or more, long-term beta-blocker use did not reduce risk for death or new MI compared with no use, researchers reported.
CPAP alternative may be better for lowering blood pressure in sleep apnea, hypertension
ATLANTA — A mandibular advancement device may be better for blood pressure lowering compared with continuous positive airway pressure devices for people with obstructive sleep apnea and hypertension, researchers reported.
Log in or Sign up for Free to view tailored content for your specialty!
Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI
ATLANTA — In the EMPACT-MI trial, empagliflozin treatment soon after an acute MI did not significantly lower risk for HF hospitalization or death from any cause compared with placebo among patients with increased risk for HF.
Enhancing HDL function does not prevent CV events after heart attack: AEGIS II
ATLANTA — Four weekly infusions of a novel formulation of human apolipoprotein A-I did not reduce a combination of CV endpoints at 90 days for adults with acute MI, multivessel disease and additional CV risk factors, researchers reported.
Childhood cancer survivors at greater risk for death after major cardiovascular event
Childhood cancer survivors appeared significantly more likely than the general public to die after a major cardiovascular event, according to study results.
FDA approves antibiotic to treat three bacterial infections
The FDA this week approved the antibiotic Zevtera for the treatment of three bacterial infections 17 years after it was first submitted to the agency.
ACC to showcase ‘exceptional’ science, mark 75 years at upcoming scientific session
The 2024 American College of Cardiology Scientific Session will be held live in Atlanta from April 6 to 8 and virtually, with 43 late-breaking trials and featured clinical research presentations.
FDA designates recall of radial artery and arterial line catheterization kits as class I
Arrow International, a subsidiary of Teleflex, has issued a recall of its radial artery and arterial line catheterization kits due to increased resistance that may cause injury to the vessel wall, vasospasm, embolism or death.
Autoimmune blistering disorders associated with elevated cardiovascular risks, death
Patients with autoimmune blistering disorders had elevated cardiovascular risks, including for atherosclerotic cardiovascular disease, heart failure, arrhythmia, venous thromboembolism and death, according to a study.
Social factors may inform CV risk assessment for certain Asian American subgroups
The impact of social determinants of health on cardiovascular risk factors may vary across Asian American subgroups such as Filipino, Asian Indian, Chinese and other Asian populations, researchers reported.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read